BioCentury
ARTICLE | Company News

StemCyte, Academia Sinica deal

December 7, 2009 8:00 AM UTC

StemCyte received an exclusive license to the university's IP and certain methods covering the use of stem cell to treat chronic stroke. The university's technology is in Phase II testing. StemCyte sa...